Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration

Dermatologic Therapy

Volumn 25, Issue 2, 2012, Pages 214-218

  Latini, Alessandra ^a   Bonadies, A ^a   Trento, E ^a   Bultrini, S ^a   Cota, C ^a   Solivetti, F M ^a   Ferraro, C ^a   Ardigo M ^a   Amorosi, B ^a   Palamara, G ^a   Bucher, S ^a   Giuliani, M ^a   Cordiali Fei, P ^a   Ensoli, F ^a   Di Carlo, A ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Classic KS; Elettrochemotherapy; HHV 8

Indexed keywords

BLEOMYCIN; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; DRUG EFFICACY; ELECTROCHEMOTHERAPY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MALE; PROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS LOAD;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; DISEASE PROGRESSION; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 8, HUMAN; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SARCOMA, KAPOSI; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862527580     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2012.01437.x     Document Type: Article

References (15)

1. Cohen A, Wolf DG, Guttman-Yassky E, Sarid R. Kapo's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit Rev Clin Lab Sci 2005: 42: 101-153. (Pubitemid 41647726)
2. Goh SG, Calonje E. Cutaneous vascular tumours: an update. Histopathology 2008: 52: 661-673. (Pubitemid 351600041)
3. Brambilla L, Miedico A, Ferrucci S, et al. Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma. J Eur Acad Dermatol Venereol 2006: 9: 1090-1094. (Pubitemid 44425966)
4. Aldenhoven M, Barlo NP, Sanders CJG. Therapeutic strategies for epidemic Kaposi's sarcoma. Int J STD AIDS 2006: 17: 571-578. (Pubitemid 44338260)
5. Garbay JR, Billard V, Bernat C, Mir LM, Morsli N, Robert C. Successful repetitive treatments by electrochemotherapy of multiple unresectable Kaposi sarcoma nodules. Eur J Cancer 2006: 4 (Suppl. 4): 29-31. (Pubitemid 44666527)
6. Testori A, Tosti G, Martinoli C, et al. Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach. Dermatol Ther 2010: 23: 651-661.
7. Gualdi G, Monari P, Fantini F, Cesinaro AM, Cimitan A. Elettrochemotherapy-induced virus disappearance in HHV-8 positive skin nodules of Kaposi's sarcoma: first histological and immunohistochemical demonstration of efficacy. J Eur Acad Dermatol Venereol 2010: 24: 231-245.
8. Guttman-Yassky E, Abada R, Kra-Oz Z, et al. Relationship between human herpesvirus 8 loads and disease stage in classic Kaposi sarcoma patients. DiagnMicrobiol Infect Dis 2007: 57: 387-392. (Pubitemid 46498653)
9. Martya M, Sersab G, Garbaya RJ, et al. Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer 2006: 4 (Suppl. 4): 3-13.
10. Trento E, Castilletti C, Ferraro C, et al. Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases. Arch Dermatol 2005: 141: 1235-1242. (Pubitemid 41498920)
11. World Health Organization (WHO). WHO handbook for reporting results of cancer treatment, Geneva 1997: 48: 22-27.
12. Jarm T, Cemazar M, Micklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010: 10: 729-746.
13. Kasper M, Barth K. Bleomycin and its role in inducing apoptosis and senescence in lung cells - modulating effects of caveolin-1. Curr Cancer Drug Targets 2009: 9: 341-353.
14. Goldberg A, Rubinsky B. The effect of electroporation type pulsed electric fields on DNA in acqueous solution. Technol Cancer Res Treat 2010: 9: 423-430.
15. Coscoy L. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat Rev Immunol 2007: 7: 391-403.